Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOHN V SHERMAN

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1871574590
CMS profile
266884
Location
GEORGETOWN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$5,489.27

14 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $4,550.00 1
Food and Beverage $615.62 12
Travel and Lodging $323.65 1

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $5,096.45 3
AbbVie, Inc. $235.84 7
Boston Scientific Corporation $123.33 1
Hologic, LLC $33.65 3

Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOHN V SHERMAN

NPI 1871574590 · CMS profile ID 266884

Allopathic & Osteopathic Physicians / Obstetrics & Gynecology

GEORGETOWN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1871574590?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOHN V SHERMAN, NPI 1871574590, CMS profile ID 266884. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1871574590?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). JOHN V SHERMAN, NPI 1871574590, CMS profile ID 266884. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1871574590?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
JOHN V SHERMAN, NPI 1871574590, CMS profile ID 266884, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1871574590?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

14 matching records · $5,489.27 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 14 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–14 of 14.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AbbVie, Inc. $23.2312/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 709097571 CMS
Hologic, LLC $4.3811/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 650004139 CMS
AbbVie, Inc. $17.7210/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647801083 CMS
AbbVie, Inc. $22.6009/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647801081 CMS
Hologic, LLC $15.4308/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 650004137 CMS
PFIZER INC. $4,550.0008/19/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673232065 CMS
AbbVie, Inc. $114.4107/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647801071 CMS
AbbVie, Inc. $17.9606/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647801069 CMS
Hologic, LLC $13.8405/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 650004133 CMS
PFIZER INC. $323.6505/10/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672257185 CMS
PFIZER INC. $222.8005/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672257191 CMS
AbbVie, Inc. $18.0304/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647801079 CMS
Boston Scientific Corporation $123.3302/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 663333081 CMS
AbbVie, Inc. $21.8902/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647801075 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,489.27 14
PY2020 $83.76 5
PY2021 $524.76 27
PY2022 $336.63 22
PY2023 $47.62 2
PY2024 $35.56 2
PY2025 $212.53 6

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $2,200.00 1
PY2023 Principal investigator $60,786.66 18
PY2022 Principal investigator $277,370.20 109
PY2021 Principal investigator $310,510.11 86
PY2020 Principal investigator $196,011.16 44
PY2019 Principal investigator $60,183.92 15

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

44 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $2,564.80 12/17/2020 Non-covered Recipient Entity
FMC Science LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742876929
Principal investigator 1 AbbVie Inc. $1,372.50 12/04/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721199643
Principal investigator 1 PFIZER INC. $14,304.93 12/03/2020 Non-covered Recipient Entity
FMC Science LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742876625
Principal investigator 1 PFIZER INC. $1,344.00 12/03/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742898773
Principal investigator 1 PFIZER INC. $3,308.20 11/18/2020 Non-covered Recipient Entity
FMC Science LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742874651
Principal investigator 1 AbbVie Inc. $9,080.35 11/12/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721195317
Principal investigator 1 PFIZER INC. $13,153.95 10/29/2020 Non-covered Recipient Entity
FMC Science LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742874935
Principal investigator 1 PFIZER INC. $1,420.30 10/17/2020 Non-covered Recipient Entity
FMC Science LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742874931
Principal investigator 1 PFIZER INC. $1,078.00 10/17/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742924645
Principal investigator 1 AbbVie Inc. $280.00 10/14/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721190897
Principal investigator 1 PFIZER INC. $19,115.00 10/01/2020 Non-covered Recipient Entity
FMC Science LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742874257
Principal investigator 1 PFIZER INC. $1,942.00 09/19/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742924195
Principal investigator 1 PFIZER INC. $10,259.20 09/18/2020 Non-covered Recipient Entity
FMC Science LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742874261
Principal investigator 1 AbbVie Inc. $320.00 09/16/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721186017
Principal investigator 1 AbbVie Inc. $9,678.20 08/19/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721181447
Principal investigator 1 PFIZER INC. $3,486.00 08/19/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742945595
Principal investigator 1 PFIZER INC. $8,554.00 08/06/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742945593
Principal investigator 1 AbbVie Inc. $808.65 08/05/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721179695
Principal investigator 1 AbbVie Inc. $189.00 07/07/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721175123
Principal investigator 1 PFIZER INC. $2,352.00 06/25/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742945885
Principal investigator 1 PFIZER INC. $2,000.00 06/16/2020 Non-covered Recipient Entity
FMC Science LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742878259
Principal investigator 1 PFIZER INC. $11,308.00 06/10/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742945883
Principal investigator 1 AbbVie Inc. $686.25 06/04/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721170247
Principal investigator 1 PFIZER INC. $1,344.00 05/13/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742965071
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $337.00 05/08/2020 Non-covered Recipient Entity
Fmc Science Llc
Bay1002670 Fibroids Efficacy US / CN No dispute reported 06/30/2026 713682631
Principal investigator 1 AbbVie Inc. $2,053.70 05/06/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721165267
Principal investigator 1 PFIZER INC. $1,344.00 05/02/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742964785
Principal investigator 1 PFIZER INC. $672.00 04/23/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742965069
Principal investigator 1 PFIZER INC. $6,475.00 04/14/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742966179
Principal investigator 1 AbbVie Inc. $5,061.50 04/03/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721159843
Principal investigator 1 PFIZER INC. $2,500.00 03/18/2020 Non-covered Recipient Entity
FMC Science LLC
A PHASE 3 RANDOMIZED DOUBLEBLINDED PLACEBOCONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY No dispute reported 06/30/2026 742879479
Principal investigator 1 PFIZER INC. $672.00 03/13/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742964781
Principal investigator 1 PFIZER INC. $3,360.00 03/10/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742964779
Principal investigator 1 AbbVie Inc. $276.75 03/05/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721154677
Principal investigator 1 PFIZER INC. $11,797.13 02/28/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742970635
Principal investigator 1 PFIZER INC. $6,664.00 02/25/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742970335
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $400.00 02/10/2020 Non-covered Recipient Entity
Fmc Science Llc
Bay1002670 Fibroids Efficacy US / CN No dispute reported 06/30/2026 713677285
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,500.00 02/10/2020 Non-covered Recipient Entity
Fmc Science Llc
Bay1002670 Fibroids Efficacy US / CN No dispute reported 06/30/2026 713677301
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,200.00 02/10/2020 Non-covered Recipient Entity
Fmc Science Llc
Bay1002670 Fibroids Efficacy US / CN No dispute reported 06/30/2026 713677321
Principal investigator 1 AbbVie Inc. $1,517.75 02/05/2020 Non-covered Recipient Entity
FMC SCIENCE LLC
M16-824 No dispute reported 06/30/2026 721149785
Principal investigator 1 PFIZER INC. $3,332.00 02/01/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742970337
Principal investigator 1 PFIZER INC. $4,648.00 01/22/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742970633
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,000.00 01/15/2020 Non-covered Recipient Entity
Fmc Science Llc
Bay1002670 Fibroids Efficacy US / CN No dispute reported 06/30/2026 713675633
Principal investigator 1 PFIZER INC. $20,251.00 01/08/2020 Non-covered Recipient Entity
FMCScience LLC
A PHASE 2 PLACEBOCONTROLLED RANDOMIZED PROOF OF CONCEPT STUDY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN PREGNANT WOMEN No dispute reported 06/30/2026 742970587

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2024 Amount invested $0.00 1
PY2024 Value of interest $1.00 1
PY2023 Amount invested $0.00 1
PY2023 Value of interest $1.00 1
PY2022 Amount invested $0.00 1
PY2022 Value of interest $1.00 1
PY2021 Amount invested $0.00 1
PY2021 Value of interest $1.00 1
PY2020 Amount invested $0.00 1
PY2020 Value of interest $1.00 1

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

5 records · PY2020–2024

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2024 Unified Women's Healthcare, LP $0.00 $1.00 Physician holds an indirect ownership interest (Interest) in the GPO through his/her in equity interest in Unified Physician Management Holdings, LP (UPM Holdings). UPM Holdings and Unified Women's Healthcare, LP, the operator of the GPO, share a common general partner, Unified Physician Management, GP, LLC. The Interest is not freely transferable, remains subject to repurchase by UPM Holdings and physicians do not receive distributions of any kind related to the GPO. Physician Covered Recipient No dispute reported 06/30/2026 1069832591
PY2023 Unified Women's Healthcare, LP $0.00 $1.00 Physician holds an indirect ownership interest (Interest) in the GPO through his/her in equity interest in Unified Physician Management Holdings, LP (UPM Holdings). UPM Holdings and Unified Women's Healthcare, LP, the operator of the GPO, share a common general partner, Unified Physician Management, GP, LLC. The Interest is not freely transferable, remains subject to repurchase by UPM Holdings and physicians do not receive distributions of any kind related to the GPO. Physician Covered Recipient No dispute reported 06/30/2026 969611557
PY2022 Unified Women's Healthcare, LP $0.00 $1.00 Physician holds an indirect ownership interest (Interest) in the GPO through his/her in equity interest in Unified Physician Management Holdings LP (UPM Holdings). UPM Holdings and Unified Women's Healthcare LP the operator of the GPO share a common general partner Unified Physician Management GP LLC. The Interest is not freely transferable remains subject to a risk of forfeiture as of the date of this filing and repurchase by UPM Holdings. Physician Covered Recipient No dispute reported 06/30/2026 862656375
PY2021 Unified Women's Healthcare, LP $0.00 $1.00 Physician holds an indirect ownership interest (Interest) in the GPO through his/her in equity interest in Unified Physician Management Holdings, LP (UPM Holdings). UPM Holdings's and Unified Women's Healthcare, LP, the operator of the GPO, share a common general partner, Unified Physician Management, GP, LLC. The Interest is not freely transferable, remains subject to a risk of forfeiture as of the date of this filing and repurchase by UPM Holdings. Physician Covered Recipient No dispute reported 06/30/2026 800888479
PY2020 Unified Women's Healthcare, LP $0.00 $1.00 Physician holds an indirect ownership interest (Interest) in the GPO through his/her in equity interest in Unified Physician Management Holdings, LP (UPM Holdings). UPM Holdings's and Unified Women's Healthcare, LP, the operator of the GPO, share a common general partner, Unified Physician Management, GP, LLC. The Interest is not freely transferable, remains subject to a risk of forfeiture as of the date of this filing and repurchase by UPM Holdings. Physician Covered Recipient No dispute reported 06/30/2026 735549363